Ready to submit
Late-Breaking Clinical Trials
Late-Breaking Clinical Trials
QICC 2026 invites late-breaking cardiovascular clinical studies with newly available findings and meaningful implications for patient care.
Present new evidence with global clinical impact
QICC 2026 invites late-breaking cardiovascular clinical studies with newly available findings and meaningful implications for patient care.
4Submission types
OnlineOfficial submission system
QICC2026 Hangzhou presentation
Overview
Call Overview
LBCT Global Call
Bring practice-changing cardiovascular evidence to QICC 2026.
Late-Breaking Clinical Trials focus on important clinical results that have not been fully presented or published. Multicenter trials, registry studies and high-impact real-world studies are encouraged.
Aug 1, 2026Submission Deadline
Requirements
Submission Materials
- Study title, authors, affiliations and corresponding author information.
- Background, objective, design, methods, primary and secondary endpoints.
- Key findings, statistical approach, conclusion and clinical relevance.
- Trial registration, ethics approval, data status and first-presentation statement.
Review Process
Review Process
Step 1Online Submission
Submit through the official QICC system and select LBCT.
Step 2Screening
The secretariat checks completeness and eligibility.
Step 3Expert Review
Experts evaluate innovation, scientific value and clinical impact.
Step 4Presentation
Selected studies will be presented at QICC 2026.
Important Dates
Key Dates
NowCall opens
Aug 1Deadline
Aug-SepReview
Nov 19-22QICC 2026
Enter Submission System